MedPath

A clinical trial to study the effects of drug loaded polymer fibers in patients with deep dental caries in primary teeth

Phase 2
Active, not recruiting
Conditions
Deep dental caries
Registration Number
CTRI/2015/05/005746
Lead Sponsor
Vishnu Dental College
Brief Summary

The study is randomized double blinded parallel group trial comparing the efficacy of Chlorhexidine gluconate loaded polymer fibers and mineral trioxide aggregate (MTA) as pulpotomy agent in 40 deciduous molars with deep dental caries was conducted in Vishnu dental College, Bhimavaram, India. The primary outcome measures were reduction of clinical signs of inflammation at 7-14days and preservation of vitality of the tooth at 3 weeks. The secondary outcomes were no clinical signs of secondary infection at 24-72hrs and 7days and on radiological evaluation no signs of root and alveolar bone resorption at 4 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
34
Inclusion Criteria

Primary teeth with clinical signs of deep dental caries involving enamel, dentin approaching pulp and with short duration of spontaneous dental pain.

Exclusion Criteria

Any tooth which exhibits signs and symptoms of pain, tenderness, chronic infection, fistula, soft tissue swelling, pathological bone loss, pathological root resorption, pathological tooth mobility.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of clinical signs of inflammation,7-14days and 3 weeks
Preservation of vitality of the tooth7-14days and 3 weeks
Secondary Outcome Measures
NameTimeMethod
Clinical signs of secondary infection,Radiological evaluation of root and alveolar bone resorption

Trial Locations

Locations (1)

Vishnu Dental College

🇮🇳

Godavari, ANDHRA PRADESH, India

Vishnu Dental College
🇮🇳Godavari, ANDHRA PRADESH, India
Dr Ravi Kalyan
Principal investigator
08816250893
dr.ravikalyan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.